Alpha Cognition
ACOG8.8002.56% ( +0.220 )
Alpha Cognition (ACOG)
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United...
- Open
- 8.710
- High
- 9.270
- Low
- 8.660
- Prev. Close
- 8.580
- Volume
- 63.65K
- Turnover
- 562.73K
- Avg Price
- 8.841
- Bid/Ask Ratio
- --
- Amplitude
- 7.11%
- 52wk High
- 10.150
- Volume Ratio
- 0.73
- Turnover Ratio
- 0.57%
Alpha Cognition Analyst Rating
View MoreForecast & Rating
Jul 10, 2026Price forecast
$16.0084.76%
Forecast & RatingBuy
4analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Jul 24 at 09:02 PM
Major Investor Doubles Down on Alpha Cognition With Bold New Stake
- benzinga_article · Jul 10 at 06:49 AM
This Travelers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- StockTitan · Jul 9 at 11:30 PM
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit | ACOG Stock News
- MSN · Jul 3 at 07:21 AM
These low-priced stocks are flashing overbought signals
- PUBT · Jun 23 at 09:36 AM
Alpha Cognition holds annual shareholder meeting
- PUBT · Jun 23 at 07:30 AM
Alpha Cognition elects Robert Wills as board chairman
